medigraphic.com

2016, Number 3

<< Back Next >>

Rev Mex Anest 2016; 39 (3)

Propofol and remifentanyl for tracheal intubation without neuromuscular relaxants with video-laryngoscope

Pedraza-Muñoz RA, Ovando-Echenique VC

Language: Spanish
References: 45
Page: 180-188
PDF size: 255.48 Kb.


ABSTRACT

Background: Since the advent of short-acting opioids, tracheal intubation was possible when these drugs are used in combination with propofol. In situations where the use of neuromuscular relaxants is unwanted, either by blocking contraindication to not have adequated monitoring or in cases where intubation is necessary but not neuromuscular relaxation; tracheal intubation can be achieved without neuromuscular relaxants when combinations of remifentanyl and propofol are used. The main objective of the study is to determine the conditions of intubation in patients undergoing anesthesia induction with propofol bolus plus infusion of remifentanyl. Material and methods: 46 patients were randomized through a sealed system into two groups (group S = no relaxing; group C = with relaxing). The induced with propofol bolus 2.3 mg/kg, the content of the syringe, infusion of remifentanyl 0.4 µg/kg/min. An expert anesthesiologist proceeded to intubate the patient through video laryngoscope. Results: 72.72% of patients who received neuromuscular relaxants showed excellent tracheal intubation conditions, while 27.27% had good condition. Conclusions: A bolus of propofol 2.3 mg/kg with an infusion of remifentanyl 0.4 µg/kg/min allow to obtain intubating conditions with video laryngoscope in 100% of cases.


REFERENCES

  1. Griffith H, Johnson, Enid G. The use of curare in general anesthesia. Anesthesiology. 1942;3:418-420.

  2. Woods a W, Allam S. Tracheal intubation without the use of neuromuscular blocking agents. Br J Anaesth. 2005;94:150-158.

  3. Fink H, Hollmann MW. Myths and facts in neuromuscular pharmacology - New developments in reversing neuromuscular blockade. Minerva Anestesiol. 2012;78:473-782.

  4. Plaud B, Debaene B, Donati F MJ. Residual paralysis after emergence from anesthesia. Anesthesiology. 2010;112:1013-1022.

  5. Schreiber JU, Mucha E F-BT. Residual paralysis following a single dose of atracurium: results from a quality assurance trial. Eur J Anaesthesiol. 2010;27:993-994.

  6. Murphy G. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period. Minerva Anestesiol. 2006;72:97-109.

  7. Berg H, Roed J, Viby-Mogensen J, Mortensen CR E, J SL. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomized, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand. 1997;41:1095-1103.

  8. Eriksson LI, Sundman E, Olsson R, Nilsson L WH, O E. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans. Simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology. 1997;87:1035-1043.

  9. Sundman E, Witt H, Olsson R, Ekberg O KR, LI. E. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans. Pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology. 2000;92:977-784.

  10. Gelberg J, Kongstad L, Werner O. Intubation conditions in young infants after propofol and remifentanil induction with and without low-dose rocuronium. Acta Anaesthesiol Scand. 2014;58:820-825.

  11. Eriksson L. Reduced hypoxic chemosensitivity in partially paralysed man. A new property of muscle relaxants? Acta Anaesthesiol Scand. 1996;40:520-523.

  12. Arbous MS, Meursing AE, van Kleef JW de LJ, Spoormans HH TP. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology. 2005;102:257-268 quiz 491-252.

  13. Long G MH. The effect on heart rate of neuromuscular blockade reversal by pyridostigmine. Anaesth Intensive Care. 1981;9:144-146.

  14. Gottlieb J, Sweet R. The antagonism of curare: the cardiac effects of atropine and neostigmine. Can Anaesth Soc J. 1963;10:114-121.

  15. Arsura EL, Brunner NG, Namba T GD. Adverse cardiovascular effects of anticholinesterase medications. Am J Med Sci. 1987;293:18-23.

  16. Pratt CI. Bronchospasm after neostigmine. Anaesthesia. 1988;43:248.

  17. Srivastava A HJ. Reversal of neuromuscular block. Br J Anaesth. 2009;103:115-129.

  18. Ponec RJ, Saunders MD KM. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med. 1999;341:137-141.

  19. Bartkowski R, R. Incomplete reversal of pancuronium neuromuscular blockade by neostigmine, pyridostigmine, and edrophonium. Anesthesia and Analgesia. 1987;66:594-598.

  20. Mencke T, Echternach M, Kleinschmidt S, Lux P, Barth V, Plinkert P, et al. Laryngeal morbidity and quality of tracheal intubation. A randomized controlled trial. Anesthesiology. 2003;98:1049-1056.

  21. Mencke T, Jacobs RM, Machmueller S, Sauer M, Heidecke C, Kallert A, et al. Intubating conditions and side effects of propofol, remifentanil and sevoflurane compared with propofol, remifentanil and rocuronium: a randomised, prospective, clinical trial. BMC Anesthesiol [Internet]. 2014;14(1):39. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4032635&tool=pmcentrez&rendertype=abstract

  22. Combes X, Andriamifidy L, Dufresne E, Suen P SS, Regimens SE. Comparison of two induction Postoperative, using or not using muscle relaxant: impact on postoperative upper airway discomfort. Br J Anaesth. 2007;99:276-281.

  23. Pang L, Zhuang YY, Dong S, Ma HC, Ma HS, Wang YF. Intubation without muscle relaxation for suspension laryngoscopy : a randomized, controlled study. Niger J Clin Pract. 2014;17:456-461.

  24. Coghlan S. Use of alfentanyl with propofol for nasotracheal intubation without neuromuscular block. Br J Anaesth. 1993;70:89-91.

  25. Grant S, Noble S, Woods A, Murdoch J, Davidson A. Assessment of intubating conditions in adults after induction with propofol and varying doses of remifentanyl. Br J Anaesth. 1998;81:540-543.

  26. Gulhas N, Topal S, Kayhan GE, Yucel A, Begec Z, Yologlu S, et al. Remifentanyl without muscle relaxants for intubation in microlaryngoscopy : a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci. 2013;17:1967-1973.

  27. Patricia Pérez Perilla, Atilio Moreno Carrillo FEGR. Guía para la secuencia de inducción e intubación rápida en el servicio de emergencias. Univ Medica. 2013;54(2):175-198.

  28. Alanoğlu Z, Tolu S, Yalçın S, Batislam Y, Özatamer O, Tüzüner F. Different remifentanyl doses in rapid sequence anesthesia induction: BIS monitoring and intubation conditions. Adv Clin Exp Med. 2013;22:47-55.

  29. Miller R. Miller anestesia. 7a ed. Eriksson L, editor. Barcelona: Elsevier; 2010.

  30. Carrillo-Esper R, Garnica-Escamilla MA, Bautista-León RC. Síndrome por infusión de propofol. 2010;33:97-102.

  31. Beers R, Camporesi E. Remifentanyl update clinical science and utility. CNS Drugs. 2004;18:1085-1104.

  32. Aldrete J, Guevara U, Capmourteres E. Texto de anestesiología teórico-práctico. 2da ed. 2004, pp. 287-320.

  33. Keaveny J, Knell P. Intubation under induction doses of propofol. Anaesthesia. 1988;43:80-81.

  34. Rincón DA, Navarro JR. Entubación con inducción de secuencia rápida: recomendaciones para el manejo de la vía aérea. Rev Colomb Anestesiol. 2004;32:89-104.

  35. Duke J. Anesthesia Secrets. Fourth. Denver, Colorado: Mosby Elsevier; 2011.

  36. Collins S, Prentice E VH. Tracheal intubation of anesth, outpatients with and without muscle relaxants. Can J Anaesth. 2000;47:427-432.

  37. McKeating K, Bali IM DJ. The effects of thiopentone and propofol on upper airway integrity. Anaesthesia. 1988;43: 638-640.

  38. Hall AP, Thompson JP, Leslie NA, Fox AJ, Kumar N. Comparison of different doses of remifentanyl on the cardiovascular response to laryngoscopy and tracheal intubation. Br J Anaesth. 2000;84:100-102.

  39. O’Hare R, McAtamney D, Mirakhur RK, Hughes D, Carabine U. Bolus dose remifentanyl for control of haemodynamic response to tracheal intubation during rapid sequence induction of anaesthesia. Br J Anaesth. 1999;82:283-285.

  40. Thompson JP, Hall AP, Russell J, Cagney B, Rowbotham DJ. Effect of remifentanyl on the haemodynamic response to orotracheal intubation. Br J Anaesth. 1998;80:467-469.

  41. Klemola UM, Mennander S, Saarnivaara L. Tracheal intubation without the use of muscle relaxants: remifentanyl or alfentanyl in combination with propofol. Acta Anaesthesiol Scand. 2000;44:465-469.

  42. McNeil IA, Culbert B, Russell I. Comparison of intubating conditions following propofol and succinylcholine with propofol and remifentanyl 2 mg kg or 4 mg kg. Br J Anaesth. 2000;85:623-625.

  43. Woods A, Grant S, Davidson A. Duration of apnoea with two different intubating doses of remifentanyl. Eur J Anaesth. 1999;16:634-637.

  44. Stevens JB, Wheatly L. Tracheal intubation in ambulatory surgery patients: using remifentanyl and propofol without muscle relaxants. Anesth Analg. 1998;86:45-49.

  45. Woods AW, Grant S, Harten J, Noble JS, Davidson Ja. Tracheal intubating conditions after induction with propofol, remifentanyl and lignocaine. Eur J Anaesth. 1998;16:714-718.




2020     |     www.medigraphic.com